Newsletter | May 26, 2026
FEATURED EDITORIAL
Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
By Jyotsna Jajula, Wayne State University
Designing repeat-dose RNA means engineering around immune recognition — optimizing payloads, purity, and delivery early to sustain efficacy, tolerability, and durability across multiple administrations.
MOST POPULAR NEWS
•
Umbrella Lab Announces Documentation & Traceability Update For Dihexa Peptide
Labcorp Launches MyLabcorp, A New AI-Powered Mobile App
Reliable, High-Performance Pump For HPLC And UHPLC
Entry Level Heat Sealer Improves Plate Sealing Consistency
CRL & MEDIPOST Sign Non-Exclusive MOU To Advance GMP Testing Solutions
Helio Genomics Announces Strategic Commercial Partnership With Syneos Health
Roche Highlights Robust Performance Of Ellis Bio SuperMethyl Kits
Valar Labs Receives FDA Breakthrough Device Designation For Vesta Bladder Risk Stratify Dx
Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities
Bracco & ACIST Medical Systems Announce U.S. FDA Clearance Of ACIST Pro Diagnostic System
Revvity Receives FDA Clearance For Total Testosterone Assay Enabling Comprehensive Automated ChLIA
